CUSIP No. 87978U108 13D
Explanatory Note:
This Amendment No. 1 (this Amendment) amends and supplements the Schedule 13D originally filed by the Reporting Persons with the Commission on
May 9, 2022 (the Original Schedule 13D). Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13D remain unchanged. Information given in response to each item shall be deemed
incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Amendment have the meanings ascribed to them in the Original Schedule 13D.
Item 1. Security and Issuer
The address of the
principal executive offices of the Issuer is 2000 Sierra Point Parkway, Suite 400, Brisbane, California, 94005.
Item 2. Identity and Background
(b) The address of the principal offices of each Reporting Person is One Sansome Street, Suite 1650, San Francisco, CA 94104.
Item 4. Purpose of Transaction
Solely on behalf of,
and only to the extent that it relates to, the Reporting Persons, Item 4 of the Original Schedule 13D is hereby amended and supplemented by the addition of the following:
The Reporting Persons have previously reserved the right and continue to reserve the right, based on all relevant factors and subject to applicable law or
other restrictions, at any time and from time to time, to acquire additional shares of Common Stock or other securities of the Issuer, dispose of some or all of the shares of Common Stock or other securities of the Issuer that it may own from time
to time, in each case in open market or private transactions, block sales or otherwise or pursuant to ordinary stock exchange transactions effected through one or more broker-dealers whether individually or utilizing specific pricing or other
instructions (including by means of Rule 10b5-1 programs), and review or reconsider their position, change their purpose, take other actions or formulate and implement plans or proposals with respect to any of
the foregoing.
The Reporting Persons intend to review their investment in the Issuer from time to time on the basis of various factors, including the
Issuers business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuers stock in particular, as well as other developments.
Item 5. Interest in Securities of the Issuer
This
information reported below is based on a total of 13,324,065 shares of the Issuers Common Stock outstanding as of August 7, 2023, as reported on the Issuers Form 10-Q filed with the Commission
on August 10, 2023. This Amendment is being filed to update the aggregate percentage of the Issuers Common Stock owned by the Reporting Persons due to dilution caused by the Issuers sales of additional shares of its Common Stock
from time to time since the date of the filing of the Original Schedule 13D. Such transactions resulted in a decrease of over one percent (1%) in the aggregate percentage ownership reported by the Reporting Persons in the Original Schedule 13D.
(a) and (b) See Items 7-11 of the cover pages of this Statement and Item 2 above.